Safety of repeated intravitreous injections of antibiotics and dexamethasone

Retina

Volumn 19, Issue 5, 1999, Pages 437-441

  Yoshizumi, Marc O ^a   Bhavsar, Abdhish R ^a   Dessouki, Amr ^b   Kashani, Amir ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endophthalmitis; Intravitreous antibiotics; Intravitreous dexamethasone; Retinal toxicity

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; DEXAMETHASONE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG SAFETY; ELECTRORETINOGRAPHY; EYE TOXICITY; HISTOPATHOLOGY; NONHUMAN; RABBIT; RETINA;

EID: 0033512358     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199919050-00014     Document Type: Article

References (25)

1. Pavan PR, Brinser JH. Exogenous bacterial endophthalmitis treated without systemic antibiotics. Am J Ophthalmol 1987; 104:121-126.
2. Pavan PR, Oteiza EE, Hughes BA, Avni A. Exogenous endophthalmitis initially treated without systemic antibiotics. Ophthalmology 1994;101:1289-1296.
3. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1995;113: 1479-1496.
4. Graham RO, Peyman G. Intravitreal injection of dexamethasone. Arch Ophthalmol 1974;92:149-154.
5. Yoshizumi MO, Equi R, Lee G, Pitchikan-Halabi H, Adamu S, Mondino B. Timing of dexamethasone treatment in Staphylococcus aureus endophthalmitis. Retina 1998;18:130-135.
6. Mao LK, Flynn HW Jr, Miller D, Pflugfelder SC. Endophthalmitis caused by Staphylococcus aureus. Am J Ophthalmol 1993;116:584-589.
7. Pflugfelder SC, Hernandez E, Fliesler SJ, Alvarez J, Pflugfelder ME, Forster RK. Intravitreal vancomycin. Arch Ophthalmol 1987;105:831-837.
8. Jay WM, Fishman P, Aziz AM, Shockley RK. Intravitreal ceftazidime in a rabbit model: dose and time-dependent toxicity and pharmacokinetic analysis. J Ocul Pharmacol 1987;3: 257-262.
9. Campochiaro PA, Green WR. Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol 1992;110:1625-1629.
10. Kwak HW, D'Amico DJ. Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. Arch Ophthalmol 1992;110:259-266.
11. Shaarawy A, Grand MG, Meredith TA, Ibanez HE. Persistent endophthalmitis after intravitreal antimicrobial therapy. Ophthalmology 1995;102:382-387.
12. Aguilar HE, Meredith TA, Shaarawy A, Kincaid M, Dick J. Vitreous cavity penetration of ceftazidime after intravenous administration. Retina 1995;15:154-159.
13. Keren G, Alhalel A, Bartov E, et al. The intravitreal penetration of orally administered ciprofloxacin in humans. Invest Ophthalmol Vis Sci 1991;32:2388.
14. El Baba FZ, Trousdale MD, Gauderman J, Wagner DG, Liggett PE. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 1992;99:483-486.
15. Lesk MR, Ammann H, Marcil G, Vinet B, Lamer L, Sebag M. The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. Am J Ophthalmol 1993;115:623-628.
16. Kowalski RP, Karenchak LM, Eller AW. The role of ciprofloxacin in endophthalmitis therapy. Am J Ophthalmol 1993; 116:695-699.
17. Donahue SP, Kowalski RP, Eller AW, DeVaro JM, Jewart BH. Empiric treatment of endophthalmitis. Arch Ophthalmol 1994; 112:45-47.
18. Mao LK, Flynn HW Jr, Miller D, Pflugfelder SC. Endophthalmitis caused by Streptococcal species. Arch Ophthalmol 1992;110:798-801.
19. Campochiaro PA, Lim JI. Aminoglycoside toxicity in the treatment of endophthalmitis. Arch Ophthalmol 1994;112:48-53.
20. Oum BS, D'Amico DJ, Wong KW. Intravitreal antibiotic therapy with vancomycin and aminoglycoside. Arch Ophthalmol 1989;107:1055-1060.
21. Oum BS, D'Amico DJ, Kwak HW, Wong KW. Intravitreal antibiotic therapy with vancomycin and aminoglycoside: examination of the retinal toxicity of repetitive injection after vitreous and lens surgery. Graefes Arch Clin Exp Ophthalmol 1992;230:56-61.
22. Aguilar HE, Meredith TA, El-Massry A, et al. Vancomycin levels after intravitreal injection. Effects of inflammation and surgery. Retina 1995;15:428-432.
23. Shaarawy A, Meredith TA, Kincaid M, et al. Intraocular injection of ceftazidime. Effects of inflammation and surgery. Retina 1995;15:433-438.
24. Boldt HC, Mieler WF. Endophthalmitis. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye, 2nd ed. Boston: Little Brown, 1996:582-583.
25. Taskintuna I, Banker AS, Rao NA, et al. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects. Exp Eye Res 1997;64:795-806.